Two Sigma Investments’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,029
| Closed | -$1.09M | – | 3069 |
|
|
2023
Q3 | $1.09M | Buy |
+27,029
| New | +$1.09M | ﹤0.01% | 1811 |
|
|
2023
Q2 | – | Sell |
-13,624
| Closed | -$4.07M | – | 2943 |
|
|
2023
Q1 | $4.07M | Buy |
+13,624
| New | +$4.07M | 0.01% | 957 |
|
|
2022
Q4 | – | Sell |
-3,531
| Closed | -$668K | – | 2756 |
|
|
2022
Q3 | $668K | Sell |
3,531
-5,236
| -60% | -$991K | ﹤0.01% | 1597 |
|
|
2022
Q2 | $1.85M | Buy |
8,767
+3,800
| +77% | +$803K | 0.01% | 1198 |
|
|
2022
Q1 | $1.66M | Buy |
4,967
+2,914
| +142% | +$975K | ﹤0.01% | 1413 |
|
|
2021
Q4 | $668K | Sell |
2,053
-1,148
| -36% | -$374K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $1.56M | Sell |
3,201
-4,984
| -61% | -$2.42M | ﹤0.01% | 1488 |
|
|
2021
Q2 | $3.81M | Sell |
8,185
-1,148
| -12% | -$534K | 0.01% | 1032 |
|
|
2021
Q1 | $6.45M | Buy |
+9,333
| New | +$6.45M | 0.02% | 735 |
|
|
2020
Q4 | – | Sell |
-1,075
| Closed | -$746K | – | 2040 |
|
|
2020
Q3 | $746K | Sell |
1,075
-3,175
| -75% | -$2.2M | ﹤0.01% | 1276 |
|
|
2020
Q2 | $3.61M | Buy |
+4,250
| New | +$3.61M | 0.02% | 663 |
|